Advertisement

Info Diabetologie

, Volume 13, Issue 5, pp 6–8 | Cite as

Die genetische Mischung macht’s

Ein Gestationsdiabetes, der keiner war

  • Jens H. StupinEmail author
aufgefallen
  • 12 Downloads

Eine augenscheinlich gesunde junge Frau erwartet ihr erstes Kind. Zunächst verläuft die Schwangerschaft regelrecht. Zu Beginn des dritten Trimenons fällt bei der Schwangeren eine erhöhte Nüchternglukose auf und das Kind wächst nicht regelrecht. Führt der milde Diabetes bei Mutter und Großmutter auf die richtige Spur?

Literatur zu Aufgefallen Mody, Dr. Jens Stupin, Charité Berlin

  1. 1.
    Chakera AJ, Steele AM, Gloyn AL, Shepherd MH, Shields B, Ellard S, Hattersley AT. Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation. Diabetes Care 2015;38:1383–92.CrossRefGoogle Scholar
  2. 2.
    Chakera AJ, Spyer G, Vincent N, Ellard S, Hattersley AT, Dunne FP. The 0,1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy. the Atlantic Diabetes in Pregnancy cohort Diabetes Care. 2014;37:1230–6.PubMedGoogle Scholar
  3. 3.
    Steele AM, Wensley KJ, Ellard S, Murphy R, Shepherd M, Colclough K, Hattersley AT, Shields BM. Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. PLoS ONE 2013;8:e65326.CrossRefGoogle Scholar
  4. 4.
    Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008;4:200–13.CrossRefGoogle Scholar
  5. 5.
    Deutsche Diabetes Gesellschaft (DDG), Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge. 2. Aufl. AWMF-Registernummer: 057/008; 2018. (Accessed 2019-05-01, at https://www.awmf.org/uploads/tx_szleitlinien/057-008l_S3_Gestationsdiabetes-mellitus-GDM-Diagnostik-Therapie-Nachsorge_2018-03.pdf)
  6. 6.
    Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001;345:971–80.CrossRefGoogle Scholar
  7. 7.
    Spyer G, Hattersley AT, Sykes JE, Sturley RH, MacLeod KM. Influence of maternal and fetal glucokinase mutations in gestational diabetes. Am J Obstet Gynecol 2001;185:240–1.CrossRefGoogle Scholar
  8. 8.
    Prisco F, Iafusco D, Franzese A, Sulli N, Barbetti F. MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of „neonatal diabetes“? Diabetologia 2000;43:1331–2.CrossRefGoogle Scholar
  9. 9.
    Steele AM, Shields BM, Wensley KJ, Colclough K, Ellard S, Hattersley AT. Prevalence of vascular complications amaong patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA 2014;311:279–86.CrossRefGoogle Scholar
  10. 10.
    de Las Heras J, Martínez R, Rica I, de Nanclares GP, Vela A, Castaño L; Spanish MODY group. Heterozygous glucokinase mutations and birth weight in Spanish children. Diabet Med 2010;27:608–10.CrossRefGoogle Scholar
  11. 11.
    Spyer G, MacLeod KM, Shepherd M, Ellard S, Hattersley AT. Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diab Med 2009;26:14–18.CrossRefGoogle Scholar
  12. 12.
    Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 1998;19:268–70.CrossRefGoogle Scholar
  13. 13.
    Singh R, Pearson ER, Clark PM, Hattersley AT. The long-term impact of exposure to hyperglycemia in utero due to maternal glucokinase gene mutations. Diabetologia 2007;50:620–4.CrossRefGoogle Scholar
  14. 14.
    Velho G, Hattersley AT, Froguel P. Maternal diabetes alters birth weight in glucokinase-deficient (MODY 2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity. Diabetologia 2000;43:1060–3.CrossRefGoogle Scholar
  15. 15.
    Dickens LT, Naylor RN, Clinical management of women with monogenic diabetes during pregnancy. Curr Diab Rep 2018;18:12.CrossRefGoogle Scholar
  16. 16.
    Bacon S, Schmid J, McCarthy A, Edwards J, Fleming A, Kinsley B, Firth A, Byrne B, Gavin C, Byrne MM. The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young. Am J Obstet Gynecol 2015;213:236.e1–7.CrossRefGoogle Scholar
  17. 17.
    Stride A, Shields B, Gill-Carey O, Chakera AJ, Colclough K, Ellard S, Hattersley AT. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. Diabetologia 2014;57:54–6.CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Klinik für GynäkologieCharité - Universitätsmedizin Berlin, Campus Virchow-KlinikumBerlinDeutschland

Personalised recommendations